Oishi et al. reported that STMN1 protein levels were significantly higher in breast cancer patients with poor prognosis than that with good prognosis, indicating that Stmn1 immnunohistostaining is a potential method for predicting the outcome of breast cancer patients with supraclavicular lymph node metastasis [34]. Here, STMN1 is linked to breast carcinoma.